Trial intelligence / Profile preview

Preoperative Intranasal Dexmedetomidine for Tonsillectomy in Children

NCT05848505Completed

Start
Feb 2022
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in tonsillar hypertrophy (2 arms). Primary endpoint: Perioperative fentanyl consumption. Started Feb 2022; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

tonsillar hypertrophy

Beyond the preview

Go deeper on NCT05848505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05848505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call